Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Nancy Hiu Lan Leung

Assistant Professor

National University of Singapore (NUS)

Singapore

Research Interests

Explore related searches

Professors in Immunology

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (8)

Logan Manikam

University College London

UNITED KINGDOM

View details

Jefferson Santos

Research Assistant Professor

University of Georgia

UNITED STATES

View details

Tim Kam Lun Tsang

Assistant Professor

The University of Hong Kong

HONG KONG

View details

Sophie A Valkenburg

Associate Professor

University of Melbourne

AUSTRALIA

View details

Patrick C. Wilson

Professor

Weill Cornell Medicine

UNITED STATES

View details

Darlington David Faijue

Co-Chief Operating Officer | Consultant

ACCESS Health International

UNITED KINGDOM

View details

Donald K Milton

Professor

University of Maryland School of Public Health

UNITED STATES

View details

Lynda Coughlan

Associate Professor

University of Maryland School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nancy Hiu Lan Leung

Research Interests

Explore related searches

Articles (20)

Influenza A (H1N1) and SARS-CoV-2 Transmission in Airplanes: Quanta Profiles and Infection Control

Repeat Influenza Vaccination Effects in 2021/22 and 2022/23 in a Community-Based Cohort in Hong Kong

Strain-specific differences in the response to egg-derived versus recombinant protein influenza vaccines

Antineuraminidase Antibody Responses in Older Adults After Consecutive Vaccinations With Enhanced Influenza Vaccines: A Randomized Controlled Trial

Population immunity, post-vaccine and post-infection antibody responses to influenza A (H3N2) subclade J.2 and K (J.2.4.1) viruses, Hong Kong, 2025

Cross-Reactive IgG Antibody Responses to SARS-CoV-2 in Older Adults Following Seasonal Coronavirus Infection in Jiangsu, China (2015–2017)

Diagnostic Performance of Self-Collected Respiratory Swabs for SARS-CoV-2 and Influenza Virus in Community-Dwelling Older Adults

Measuring population immunity against influenza using individual antibody titres: a multicountry, retrospective observational study

Near real-time data on the human neutralizing antibody landscape to influenza virus as of early 2026 to inform vaccine-strain selection

CHIP toolkit: Social mapping and transect walk for childhood infection and pollution – A comparative study across four cities (Jaipur, Jakarta, Antofagasta, and Istanbul)

Enhanced Influenza Vaccines Extend A(H3N2) Antibody Reactivity in Older Adults but Prior Vaccination Effects Persist

Long-lasting B cell convergence to distinct broadly reactive epitopes following vaccination with chimeric influenza virus hemagglutinins

New WHO proposed terminology for respiratory pathogen transmission

Antibody Fc receptor binding and T cell responses to homologous and heterologous immunization with inactivated or mRNA vaccines against SARS-CoV-2

Preliminary Findings From the Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE I) Study: A Randomized Controlled Trial

Influenza antibody breadth and effector functions are immune correlates from acquisition of pandemic infection of children

Durability for 12 months of antibody response to a booster dose of monovalent BNT162b2 in adults who had initially received 2 doses of inactivated vaccine

High-throughput sequencing-based neutralization assay reveals how repeated vaccinations impact titers to recent human H1N1 influenza strains

Understanding one health challenges in marginalized urban settings: A patient and public involvement (PPI) approach from the CHIP consortium activities across four global cities

A(H2N2) and A(H3N2) influenza pandemics elicited durable cross-reactive and protective antibodies against avian N2 neuraminidases

Collaborators (8)

Logan Manikam

Jefferson Santos

Tim Kam Lun Tsang

Sophie A Valkenburg

Patrick C. Wilson

Darlington David Faijue

Donald K Milton

Lynda Coughlan

Make your next move.